Pharmaceutical - Pharmaceutical


Current filters:


Popular Filters

151 to 175 of 6821 results

Ukraine on verge of sharp rise in drug prices


Prices for drugs in Ukraine are steadily increasing, amid the ongoing political and economical crisis…

Eastern EuropePharmaceuticalPricingUkraine

Otsuka’s Samsca, first ADPKD therapy, approved in Japan


Japanese drugmaker Otsuka Pharmaceutical says it has become the first company in the world to obtain…

Asia-PacificJapanNephrology and HepatologyOtsukaPharmaceuticalRegulationSamsca

Janssen’s guselkumab shows significant efficacy in moderate to severe plaque psoriasis


New findings presented for the first time at the 2014 Annual Meeting of the American Academy of Dermatology…

DermatologicalsguselkumabHumiraJanssenJohnson & JohnsonPharmaceuticalResearch

Foreign drug producers continue to dominate in the Russian pharmaceutical market


Foreign drug producers continue to dominate in the Russian pharmaceutical market, despite the attempts…

Eastern EuropeMarkets & MarketingPharmaceuticalProductionRussia

Patent lawyer seeking US Senate seat proposes patent reform to lower Rx drug costs


Republican Art Gardner, a patent attorney seeking election to the US Senate in Georgia, has issued a…

North AmericaPatentsPharmaceuticalPoliticsPricingUSA

Medimetriks licenses ozenoxacin, a novel antibacterial, from Ferrer


US specialty drug firm Medimetriks Pharmaceuticals has entered into a licensing agreement with Ferrer,…

Antibiotics and Infectious diseasesFerrer InternacionalLicensingMedimetriks PharmaceuticalsNorth AmericaOzenoxacinPharmaceuticalUSA

Astellas’ Xtandi cleared in Japan for prostate cancer treatment


Japanese drug major Astellas Pharma has obtained the marketing approval in Japan of its oral androgen…

Asia-PacificAstellas PharmaJapanMedivationOncologyPharmaceuticalRegulationXtandi

Positive CHMP opinion for Janssen’s simeprevir for chronic hepatitis C


US health care giant Johnson & Johnson’s European subsidiary Janssen R&D Ireland has received a positive…

Anti-viralsEuropeJanssenJohnson & JohnsonMedivirOlysioPharmaceuticalRegulationsimeprevir

Japanese approval for Forxiga and Lonsurf


Anglo-Swedish drug major AstraZeneca says that Japanese Ministry of Health, Labor and Welfare approved…

Asia-PacificAstraZenecaDiabetesForxigaJapanLonsurfOncologyOno PharmaceuticalOtsukaPharmaceuticalRegulationTaiho Pharmaceutical

Ukraine MoH signs “understanding” with insulin producers


On March 19, Oleg Musiy, the Minister of Health in Ukraine, signed the memorandum of understanding with…

DiabetesEastern EuropeHealthcarePharmaceuticalPricingUkraine

Mixed Ph III data for Pfizer’s tofacitinib vs Enbrel in plaque psoriasis


US pharma giant Pfizer has announced detailed results from OPT Compare (A3921080), a Phase III study…


Use of mood stabilizing drug linked with reduced risk of developing head and neck cancer


A new study indicates that a commonly used mood stabilizing drug may help prevent head and neck cancer.…

NeurologicalOncologyPharmaceuticalResearchValproic Acid

UK’s NICE unable to give the go ahead to new prostate cancer drug Xofigo


The UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has issued new draft…

BayerNorthern EuropeOncologyPharmaceuticalPricingRegulationUKXofigo

India urged to take action on unregulated tuberculosis drug sales


Although cases of tuberculosis are dropping in Europe, as is the incidence in the USA, an extremely slower…

Antibiotics and Infectious diseasesAsia-PacificHealthcareIndiaPharmaceuticalResearch

EMA/CHMP recommends empagliflozin for approval for type 2 diabetes


German family-owned drug major Boehringer Ingelheim and partner Eli Lilly of the USA have announce a…

Boehringer IngelheimDiabetesEli LillyempagliflozinEuropeJardiancePharmaceuticalRegulation

EMA/CHMP backs approval of Merck ovarian cancer drug Vynfinit and companion diagnostics


The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended…

EndocyteEuropeFolcepriMerck & CoNeocepriOncologyPharmaceuticalRegulationVynfinit

Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease


Takeda Pharmaceutical, Japan’s largest drugmaker, today received a positive opinion form the European…

EntyvioEuropeGastro-intestinalsPharmaceuticalRegulationTakeda Pharmaceuticals

Label updates for Tresiba and Victoza backed by EMA committee


The European Medicines agency’s Committee for Medicinal Products for Human Use has issued positive…

DiabetesEuropeNovo NordiskPharmaceuticalRegulationTresibaVictoza

Health Canada approves Biogen Idec’s long-acting Alprolix hemophilia B

Health Canada approves Biogen Idec’s long-acting Alprolix hemophilia B


US biotech firm Biogen Idec has announced that Health Canada has approved Alprolix for the control and…

AlprolixBiogen IdecCanadaHematologyPharmaceuticalRegulation

UK about turn, as JCVI now recommends meningitis B vaccination for infants


The UK’s Joint Committee on Vaccination and Immunization has recommended that the meningitis B vaccine…

BexseroNorthern EuropeNovartisPharmaceuticalRegulationUKVaccines

Structuring your investment to protect IP rights – the case of compulsory licensing


Pharmaceutical companies may obtain additional international law protection against unlawful compulsory…


Improving awareness of unfashionable cancers

Improving awareness of unfashionable cancers


Here's our take on the week's top stories.


Positive mid-stage results for Forest Labs and Gedeon Richter’s cariprazine in MDD


US drugmaker Forest Laboratories and Gedeon Richter, Hungary’s largest pharma company, have released…

cariprazineForest LaboratoriesGedeon RichterNeurologicalPharmaceuticalResearch

New survey confirms psoriasis and psoriatic arthritis patients frequently undertreated or not treated at all


A unique and extensive survey provides the first-of-its-kind multinational look into the impact psoriasis…


151 to 175 of 6821 results

Back to top